Operational barriers like complicated workflows and long turnaround times have hindered broad adoption of next-generation sequencing (NGS) in clinical oncology research. The new Ion Torrent Genexus ...
In the past years, next-generation sequencing has revolutionized the way testing is done in the field of clinical oncology research. Parallel testing of genomic markers in tissue biopsies as well as ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific today launched the CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer, an automated, next-generation sequencing (NGS) platform that ...
Thermo Fisher Scientific has announced the launch of its Ion Torrent Genexus System, a fully integrated, next-generation sequencing (NGS) platform featuring an automated specimen-to-report workflow ...
Mumbai: Thermo Fisher Scientific, received breakthrough device designation for its Oncomine Precision Assay by the U.S. Food and Drug Administration (FDA). The assay can be used to identify low-grade ...
Clinical researchers who take a traditional sequential approach to analyze myeloid malignancies, a highly heterogeneous group of disorders, face a major hurdle: a laborious and time-consuming workflow ...
Next-generation sequencing (NGS) can play a key role in precision medicine approaches, enabling clinicians to select treatments most likely to benefit patients, based on their genomic profiles.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results